Nathan McCutcheon shares highlights of Qpex Biopharma’s acquisition by Shionogi

Shots: Nathan McCutcheon, President, and Chief Executive Officer of Shionogi, shares the highlights of the recent acquisition of Qpex Biopharma by Shionogi Nathan believes that Qpex’s specialized expertise and extensive experience in chemistry and molecular design are sure to strengthen and be useful for the combined antibiotic pipeline The acquisition provides Shionogi exclusive development, manufacturing,…

BySaurabh ChaubeyOctober 16, 2023

EVENTS

Webinar Recap: Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma Sectors

Intuitive, informative, and gripping, could be an articulate three-word summarization of our recent webinar on Competitive Intelligence. October 5th, 2023, the day PharmaShots organized a webinar dedicated to competitive intelligence and navigated the nuances that go beyond the conventional definition of CI. Titled "Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma…

BySaurabh ChaubeyOctober 11, 2023

THOUGHTSPOT

4 Steps To Ensure Clinical Trial Compliance

When performing research studies, clinical trial compliance plays a vital part in ensuring the safety and effectiveness of the research. It means adhering to ethical and regulatory requirements established by governing bodies that guarantee the well-being of study participants and the legitimacy of study results. Sponsors, investigators, and study sites could face considerable legal and…

ByAdrian WallaceApril 26, 2023

EXCLUSIVE

Iris Loew-Friedrich, CMO and Head of Development Solutions at UCB Shares her Thoughts on the Launch of New Innovators Campaign

Shots: Iris shared the specifics of the launch of the UCB’s Innovators campaign. The campaign spotlights the R&D employees’ perspectives on innovation and aims to highlight why innovation is a key driving force at UCB for bettering the lives of patients She gave her thoughts on how UCB is adopting innovative AI programs that use…

BySenior EditorMarch 6, 2023

THOUGHTSPOT

Accelerating the Transition Between Antibody Research and Production

Speed is of the essence - while this statement may be somewhat worn thin, it is still - and particularly true in an industry that deals with developing and producing curative if not life-saving products. Especially fields such as biopharmacy and bioprocessing - both of which are fast-paced and seemingly reinventing themselves on a regular…

BySenior EditorJune 7, 2022

THOUGHTSPOT

The New Normal and Covid-19 Vaccine Development

Since the virus outbreak in China, all eyes are on the most awaited Covid-19 vaccine offering a glimmer of hope. Abide by social distancing, wearing a mask, and frequent hand washing - until we have a vaccine. This new mantra amidst all misery has created hope in the hearts of many. We have to accept…

BySenior EditorAugust 5, 2020

EVENTS

DIA India Medical Devices Conference from 21-22 February 2020 I New Delhi, India

The Medical Devices Conference hosted by DIA India on 21st and 22nd February in collaboration with Medical Technology Association of India (MTaI), AIC-AMTZ Medivalley Incubation Council and mDI Europa, is one of the largest gatherings of medical devices professionals in the region. This initiative is a first for DIA in India and holds promise to…

BySenior EditorFebruary 13, 2020

Nathan McCutcheon shares highlights of Qpex Biopharma’s acquisition by Shionogi

Webinar Recap: Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma Sectors

4 Steps To Ensure Clinical Trial Compliance

Iris Loew-Friedrich, CMO and Head of Development Solutions at UCB Shares her Thoughts on the Launch of New Innovators Campaign

Accelerating the Transition Between Antibody Research and Production

The New Normal and Covid-19 Vaccine Development

DIA India Medical Devices Conference from 21-22 February 2020 I New Delhi, India

Contact US

FOLLOW US